BTC Health PEG
The PEG Ratio (Price/Earnings-to-Growth) of BTC Health (BTC.AX) as of Jul 18, 2026 is 0.03. In the previous year, PEG Ratio (Price/Earnings-to-Growth) was 0.17 — a change of -80.07% (lower).
Get this data via API
Financial Data API
PEG
0.03
YoY
-80.07%
Last updated:
PEG Ratio (Price/Earnings-to-Growth) of BTC Health is 2026 0.03 . PEG Ratio (Price/Earnings-to-Growth) of BTC Health was 2025 0.17 . It decreases by -80.07% lower compared to the previous year.
Access this data via the Eulerpool API
BTC Health Stock analysis
What does BTC Health do? BTC Health Ltd is a British company specializing in the production and distribution of medical devices and pharmaceuticals. The company was founded in 2005 and is headquartered in London.
Business model
BTC Health Ltd's business model is based on the manufacturing and distribution of medical devices and pharmaceuticals that meet the highest quality standards. The company works closely with medical professionals and research institutions to develop innovative products that meet the needs of patients and healthcare providers.
Divisions
BTC Health Ltd is divided into several divisions, each offering different products and services. The main divisions are:
- Medical Technology
- Diagnostics
- Pharmaceuticals
Medical Technology
The Medical Technology division manufactures a wide range of medical devices, including ventilators, infusion pumps, defibrillators, and patient monitors. These devices are used in hospitals, clinics, and care facilities to accurately monitor and treat patients.
Diagnostics
The Diagnostics division offers a variety of laboratory and diagnostic products, including blood glucose monitors, test strips, immunassays, and ELISA kits. These products are used for the rapid and reliable identification of diseases, enabling effective treatment.
Pharmaceuticals
The Pharmaceuticals division specializes in the production and distribution of innovative pharmaceuticals specifically developed for the treatment of rare diseases and serious illnesses. Products include cancer medications, antibody therapeutics, and treatments for rare metabolic disorders.
Products
BTC Health Ltd offers a wide range of medical devices and pharmaceuticals that meet the highest quality standards. Some of the key products include:
- VasoPress (medication for the treatment of low blood pressure)
- Episcan (ultrasound device for early detection of breast cancer)
- Novotest (test for diagnosing kidney dysfunction)
- Bongo (infusion pump for medication dosing)
- Nonin Xpod (patient monitor for monitoring vital signs)
Conclusion
BTC Health Ltd is a leading company in the production and distribution of medical devices and pharmaceuticals. The company is committed to developing innovative products that meet the needs of patients and healthcare providers. With a wide range of products in various divisions, BTC Health Ltd is well positioned to be an important partner in the healthcare industry in the future. BTC Health is one of the most popular companies on Eulerpool.
Frequently Asked Questions about BTC Health stock
PEG Ratio (Price/Earnings-to-Growth) of BTC Health is 0.03 in 2026.
Access this data via the Eulerpool API
Valuation — BTC Health
All Key Metrics — BTC Health
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth